Assignee
INST CURIE
FR·51 granted patents·87 pending applications·246 citations·filing 1997–2025
Top patents by PatentIndex Score
138 records- 0187US11285176B2Immune cells defective for Suv39h1INST CURIE·Filed 2021·Granted Mar 29, 2022·1 cites·13 claims
- 0287US7718601B2Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to Gb3 expressing tumorsINST CURIE·Filed 2005·Granted May 18, 2010·5 cites·23 claims
- 0386US12371471B2Immune cells defective for SUV39H1INST CURIE·Filed 2024·Granted Jul 29, 2025·0 cites·16 claims
- 0484US7981400B2Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to GB3 expressing tumorsINST CURIE·Filed 2010·Granted Jul 19, 2011·5 cites·39 claims
- 0584US7741308B2DBAIT and uses thereofINST CURIE·Filed 2008·Granted Jun 22, 2010·6 cites·23 claims
- 0683US7632514B2Universal carrier for targeting molecules to Gb3 receptor expressing cellsINST CURIE·Filed 2003·Granted Dec 15, 2009·11 cites·11 claims
- 0782US10576103B2Immune cells defective for SUV39H1INST CURIE·Filed 2019·Granted Mar 3, 2020·3 cites·18 claims
- 0882US9347915B2Non-thermosensitive medium for analyzing species in a channel and for minimizing absorption and/or electroosomosic phenomenaINST CURIE·Filed 2015·Granted May 24, 2016·2 cites·1 claims
- 0981US10010607B2Method for preparing viral particles with cyclic dinucleotide and use of said particles for inducing immune responseINST CURIE·Filed 2015·Granted Jul 3, 2018·6 cites·21 claims
- 1081US7476729B2Dbait and uses thereofINST CURIE·Filed 2006·Granted Jan 13, 2009·4 cites·23 claims
- 1180US11622978B2Immune cells defective for SUV39H1INST CURIE·Filed 2020·Granted Apr 11, 2023·1 cites·23 claims
- 1280US6879394B2Multi-photon imaging installationINST CURIE·Filed 2003·Granted Apr 12, 2005·32 cites·51 claims
- 1379US10603265B2Skin whitening peptide agentsINST CURIE·Filed 2015·Granted Mar 31, 2020·3 cites·10 claims
- 1478US2023201264A1Immune cells defective for suv39h1INST CURIE·Filed 2023·Application pending·0 cites
- 1577US11162095B2Use of a combination of Dbait molecule and PARP inhibitors to treat cancerINST CURIE·Filed 2020·Granted Nov 2, 2021·1 cites·16 claims
- 1677US10661278B2Device for manipulation of packets in micro-containers, in particular in microchannelsINST CURIE·Filed 2016·Granted May 26, 2020·1 cites·13 claims
- 1777US2024216388A1Inhibitor of suv39h1 histone methyltransferase for use in cancer combination therapyINST CURIE·Filed 2024·Application pending·0 cites
- 1876US9658189B2Non-thermosensitive medium for analyzing species in a channel and for minimizing adsorption and/or electroosomosic phenomenaINST CURIE·Filed 2016·Granted May 23, 2017·1 cites·28 claims
- 1974US7115608B2Pyridinone and pyridinethione derivatives having HIV inhibiting propertiesINST CURIE·Filed 2001·Granted Oct 3, 2006·8 cites·9 claims
- 2072US7279334B2Methods for inducing targeted stimulation of meiotic recombination and kits for performing said methodsINST CURIE·Filed 2005·Granted Oct 9, 2007·4 cites·22 claims
- 2171US10563197B2Use of a combination of Dbait molecule and PARP inhibitors to treat cancerINST CURIE·Filed 2016·Granted Feb 18, 2020·1 cites·26 claims
- 2271US7595302B2Nucleic acids useful for triggering tumor cell lethalityINST CURIE·Filed 2004·Granted Sep 29, 2009·5 cites·22 claims
- 2371US6830670B1Heat-sensitive medium for separating species in a separating channel and use thereofINST CURIE·Filed 1999·Granted Dec 14, 2004·43 cites·33 claims
- 2470US6862923B2Atomic force microscopeINST CURIE·Filed 2001·Granted Mar 8, 2005·31 cites·15 claims
- 2569US12371741B2Method for detecting a mutation in a microsatellite sequenceINST CURIE·Filed 2024·Granted Jul 29, 2025·0 cites·9 claims
- 2669US2024247318A1Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumorsINST CURIE·Filed 2024·Application pending·0 cites
- 2768US11097275B2Device for manipulation of packets in micro-containers, in particular in microchannelsINST CURIE·Filed 2020·Granted Aug 24, 2021·0 cites·13 claims
- 2868US9603923B2Universal carrier for targeting molecules to GB3 receptor expressing cellsINST CURIE·Filed 2014·Granted Mar 28, 2017·0 cites·11 claims
- 2968US9469840B2Device for guiding cell migration and method of guiding cell migration implementing such a deviceINST CURIE·Filed 2012·Granted Oct 18, 2016·1 cites·33 claims
- 3068US2019204266A1Non-thermosensitive medium for analyzing species in a channel and for minimizing adsorption and/or electroosomosic phenomenaINST CURIE·Filed 2018·Application pending·0 cites
- 3167US12252517B2Hook fusion protein for regulating the cellular trafficking of a target proteinINST CURIE·Filed 2023·Granted Mar 18, 2025·0 cites·9 claims
- 3266US2025213614A1Modified RELA Protein for Inducing Interferon Expression and Engineered Immune Cells with Improved Interferon ExpressionINST CURIE·Filed 2023·Application pending·0 cites
- 3366US2026008748A1Compounds with biguanidyl radical and uses thereofINST CURIE·Filed 2025·Application pending·0 cites
- 3466US2025241949A1Myeloid cells modified by chimeric antigen receptor and uses thereof for anti-cancer therapyINST CURIE·Filed 2023·Application pending·0 cites
- 3565US2025163113A1PEPTIDES TARGETING THE INTERACTION BETWEEN KINDLIN-1 AND Beta-INTEGRININST CURIE·Filed 2023·Application pending·0 cites
- 3664US2024101616A1Dap10/12 based cars adapted for rushINST CURIE·Filed 2023·Application pending·0 cites
- 3763US12152077B1Immunotherapy targeting tumor neoantigenic peptidesINST CURIE·Filed 2023·Granted Nov 26, 2024·0 cites·9 claims
- 3863US2025222106A1Myeloid cells modified by chimeric antigen receptor with cd40 and uses thereof for anti-cancer therapyINST CURIE·Filed 2023·Application pending·0 cites
- 3963US2018024095A1Non-thermosensitive medium for analyzing species in a channel and for minimizing adsorption and/or electroosomosic phenomenaINST CURIE·Filed 2017·Application pending·0 cites
- 4062US2025170422A1Device, apparatus and method for minibeam radiation therapyINST CURIE·Filed 2024·Application pending·0 cites
- 4162US2025304915A1Myeloid Cells Overexpressing BCL2INST CURIE·Filed 2022·Application pending·0 cites
- 4261US2011190627A1Method and Device for Marking a Medium, and Marker Usable in Such a MethodINST CURIE·Filed 2009·Application pending·0 cites
- 4361US2025302930A1Immunotherapy targeting tumor transposable element derived neoantigenic peptides in glioblastomaINST CURIE·Filed 2023·Application pending·0 cites
- 4461US2026048106A1Immunotherapy targeting tumor transposable element derivedneoantigenic peptides in glioblastomaINST CURIE·Filed 2025·Application pending·0 cites
- 4561US2024423927A1Compositions and methods for use in immunotherapyINST CURIE·Filed 2022·Application pending·0 cites
- 4661US2024269282A1Methods for the Treatment of Cancer, Inflammatory Diseases and Autoimmune DiseasesINST CURIE·Filed 2022·Application pending·0 cites
- 4760US7371742B2Porphyrin derivatives for photodynamic therapyINST CURIE·Filed 2002·Granted May 13, 2008·3 cites·17 claims
- 4860US2020157225A1Inhibitor of suv39h1 histone methyltransferase for use in cancer combination therapyINST CURIE·Filed 2020·Application pending·0 cites
- 4960US2020147099A1Inhibitor of suv39h1 histone methyltransferase for use in cancer combination therapyINST CURIE·Filed 2018·Application pending·0 cites
- 5060US2023117652A1Method for Detecting a Mutation in a Microsatellite SequenceINST CURIE·Filed 2022·Application pending·0 cites
Showing the top 50 of 138 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →